Results 21 to 30 of about 32,063 (268)
Comparative Analysis of Clinical and Imaging Features of Osteomalacia and Spondyloarthritis
Frontiers in Medicine, 2021 Aim: To compare the clinical and radiological characteristics of osteomalacia and spondyloarthritis/ankylosing spondylitis (SpA/AS) in order to provide a basis for differential diagnosis.Methods: We carried out a retrospective analysis of patients who ...
Zheng Zhao +6 more
doaj +1 more source
Diagnosis and Management of Tumor-induced Osteomalacia: Perspectives From Clinical Experience
Journal of the Endocrine Society, 2021 Purpose Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome of abnormal phosphate and vitamin D metabolism caused by typically small endocrine tumors that secrete fibroblast growth factor 23 (FGF23).
K. Dahir +10 more
semanticscholar +1 more source
Nasal Hemangiopericytoma Causing Oncogenic Osteomalacia [PDF]
Clinical and Experimental Otorhinolaryngology, 2012 Oncogenic osteomalacia is a rare cause that makes abnormalities of bone metabolism. Our case arose in a 47-year-old woman presenting a nasal mass associated with osteomalacia. We excised the mass carefully.
Sung Il Cho +3 more
doaj +1 more source
Oncogenic osteomalacia secondary to glomus tumor
Endocrinology, Diabetes & Metabolism Case Reports, 2021 Oncogenic osteomalacia secondary to glomus tumor is extremely rare. Localization of causative tumors is critical as surgical resection can lead to a complete biochemical and clinical cure.
Rishi Raj +10 more
doaj +1 more source
Severe FGF23-based hypophosphataemic osteomalacia due to ferric carboxymaltose administration [PDF]
BMJ Case Reports, 2018 Klara R. Klein +3 more
openalex +2 more sources
Nutrients, 2022 Nutrition-acquired osteomalacia is a bone mineralization disorder associated with dietary calcium and/or solar vitamin D deficiency, risk factors considered common in the Middle Eastern region.
N. Al-Daghri +7 more
semanticscholar +1 more source
Epidemiology of Tumor-Induced Osteomalacia in Denmark
Calcified Tissue International, 2021 Tumor-induced osteomalacia (TIO) is a rare, acquired condition of phosphate wasting due to phosphaturic mesenchymal tumors. Because the incidence and prevalence of TIO is unknown, we conducted an observational cohort study using national Danish health ...
B. Abrahamsen +2 more
semanticscholar +1 more source
Refractory Hypophosphatemia Secondary to Tumor-Induced Osteomalacia: Diagnostic Challenges and Successful Management With Burosumab. [PDF]
CureusRamzan A, Lodhi FAK, Ramzan F.
europepmc +3 more sources
Burosumab for the Treatment of Tumor‐Induced Osteomalacia
Journal of Bone and Mineral Research, 2020 Tumor‐induced osteomalacia (TIO) is caused by phosphaturic mesenchymal tumors producing fibroblast growth factor 23 (FGF23) and is characterized by impaired phosphate metabolism, skeletal health, and quality of life.
S. M. Jan de Beur +11 more
semanticscholar +1 more source
Fluoridated Water-Induced Osteomalacia in the Population of Mirpurkhas
JLUMHS, 2023 OBJECTIVE: To investigate the prevalence and impact of fluoridated water consumption on osteomalacia in the population of Mirpurkhas, focusing on understanding the relationship between fluoride levels in water sources and the incidence of osteomalacia ...
Mir Mehrab Jan Khetran +5 more
doaj +1 more source